References
- Saito I, Saruta T. Effect of education through a periodic newsletter on persistence with antihypertensive therapy. Hypertens Res 2003;26:159–62
- Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003;326:1427–34
- Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007;120:713–19
- Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010;55:399–407
- Sherrill B, Halpern M, Khan S, et al. Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence. J Clin Hypertens 2011;13:898–909
- Saito I. Medication compliance and blood pressure control. J Blood Pressure 2006;13:1019–25 (in Japanese)
- Matsumura K, Arima H, Tominaga M, et al. for the COMFORT Investigators. Does a combination pill of antihypertensive drugs improve medication adherence in Japanese? Circ J 2012;76:1415–22
- Kitai T, Murata E, Uehara Y, et al. Use-result surveillance of azelnidipine (Calblock® Tab). J Clin Ther Med 2005;21:511–27 (in Japanese)
- Saito I, Kushiro T, Yamakawa M, et al. Drug use result survey of Olmetec® tablets (olmesartan medoxomil). J Clin Ther Med 2013;29:967–87 (in Japanese)
- Saito I, Kushiro T, Sato Y, et al. Drug use result survey of Rezaltas® combination tablets (olmesartan medoxomil/azelnidipine) for 12 weeks. J Clin Ther Med 2006;22:873–93 (in Japanese)
- Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41–55
- Austin PC. Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations. Biometr J 2009;51:171–84
- Austin PC, Chiu M, Ko DT, et al. Propensity score matching for estimating treatment effects. In: Faries DE, Leon AC, Haro JM, Obenchain RL, eds. Analysis of observational health care data using SAS. Cary, NC: SAS Institute Inc.; 2010: Chapter 3, 51–84
- Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:455–61
- Corrao G, Parodi A, Nicotra F, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens 2011;29: 610–18
- Ministry of Health, Labour and Welfare. Overview of medical facilities survey and hospital report. Available from: http://www.mhlw.go.jp/toukei/saikin/hw/iryosd/13/ [last accessed 14 April 2015]
- Osterber L, Blascheke T. Adherence to medication. N Engl J Med 2005;353:487–97
- Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008;10: 348–54
- Wang TD, Chen YH, Huang CH, et al. Bidirectional adherence changes and associated factors in patients switched from free combinations to equivalent single-pill combinations of antihypertensive drugs. Hypertension 2014;63:958–67
- Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009;120:1598–605
- Perreault S, Dragomir A, Roy L, et al. Adherence level of antihypertensive agents in coronary artery disease. Br J Clin Pharmacol 2010;69:74–84
- Herttua K, Tabak AG, Martikainen P, et al. Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: population-based study. Eur Heart J 2013;34:2933–9
- Krousel-Wood M, Holt E, Joyce C, et al. Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the Cohort Study of Medication Adherence among Older Adults (CoSMO). J Hypertens 2015;33:412–20